Clinical Trial Update: A Comparison of Propofol Versus Midazolam to Sedate Critically Brain Injury; Measurement of Cytokine Response and Assessment of Function [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing propofol and midazolam for sedation in patients with traumatic brain injury was terminated. Results were posted on 2025-06-26…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Midazolam (Midazolam)
• PROPOFOL (Propofol)

Snippet

Sponsor: Michigan State University | Conditions: Traumatic Brain Injury | Phase 4 | Status: TERMINATED | Results posted: 2025-06-26